NOVARTIS PHARMA AG

CIK 1030617 · last filed 2012-09-24

NOVARTIS PHARMA AG is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing shows the insider sold $60.3M of ALNY on Sep 24, 2012. Across all open-market trades the lifetime net is −$58.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.08B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.08B

Companies

2

Total Filings

9

Lifetime Open-Market Net

-$58.56M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALNY 10%+ Owner 4,051,002 $267.47 $1.08B -$60.28M 1 2012-09-24
IDENIX PHARMACEUTICALS INC (IDIX) Delisted 10%+ Owner 33,271,882 $1.72M 8 2012-02-23

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-09-24 ALNY Sell (S) −3,103,792 -$60.28M EDGAR
2012-02-23 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +169,786 $582.6K EDGAR
2011-12-09 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +53,528 $229.0K EDGAR
2011-11-22 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +101,060 $412.8K EDGAR
2010-11-26 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +34,166 $93.4K EDGAR
2010-09-16 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +74,428 $182.0K EDGAR
2010-08-23 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +74,428 $182.0K EDGAR
2010-02-26 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +3,744 $9.0K EDGAR
2009-02-23 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Buy (P) +10,888 $26.2K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.